Literature DB >> 8627540

Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats.

K Fecho1, K A Maslonek, L A Dykstra, D T Lysle.   

Abstract

The present study examined the involvement of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis in the immunomodulatory effects of acute morphine treatment in rats. Chlorisondamine, a ganglionic blocker, was used to assess the involvement of sympathetic and sympathoadrenal activity. Adrenalectomized rats were used to assess the involvement of the adrenal cortex, which is regulated primarily by hypothalamic-pituitary-adrenal axis activity, and the adrenal medulla, which is regulated primarily by sympathetic activity. The results showed that both chlorisondamine and adrenalectomy antagonize morphine's suppressive effects on the proliferative response of splenic lymphocytes to concanavalin A (Con A), lipopolysaccharide or ionomycin/phorbol myristate acetate. Chlorisondamine, but not adrenalectomy, antagonizes morphine's suppressive effects on phytohemagglutinin (PHA)-stimulated proliferation of splenic lymphocytes and interferon-gamma production by stimulated splenocytes. Adrenalectomy, but not chlorisondamine, blocks morphine's suppressive effects on the proliferative response of blood lymphocytes to Con A or PHA. Neither chlorisondamine nor adrenalectomy alters morphine's suppressive effect on splenic natural killer cell cytotoxicity. Collectively, these results suggest that sympathoadrenal activity is involved in the suppressive effects of acute morphine treatment on the proliferative response of splenic T and B cells to Con A, lipopolysaccharide or ionomycin/phorbol myristate acetate. Morphine's suppressive effects on the proliferative response of splenic T cells to PHA and the production of interferon-gamma by stimulated splenocytes also involve sympathetic activity, but not sympathoadrenal activity. The results suggest further that morphine's suppressive effects on the proliferative response of blood T cells to Con A or PHA do not involve sympathetic activity, but rather adrenocortical activity. Neither sympathetic nor adrenocortical activity appears to be involved in morphine's suppressive effect on splenic natural killer cell cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627540

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  16 in total

Review 1.  Modulation of immune function by morphine: implications for susceptibility to infection.

Authors:  Sabita Roy; Jinghua Wang; Jennifer Kelschenbach; Lisa Koodie; Josephine Martin
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

2.  Ventral tegmental area-basolateral amygdala-nucleus accumbens shell neurocircuitry controls the expression of heroin-conditioned immunomodulation.

Authors:  Jennifer L Szczytkowski; Rita A Fuchs; Donald T Lysle
Journal:  J Neuroimmunol       Date:  2011-07-01       Impact factor: 3.478

3.  Morphine suppresses MHC-II expression on circulating B lymphocytes via activation of the HPA.

Authors:  Alexandria L Nugent; Richard A Houghtling; Barbara M Bayer
Journal:  J Neuroimmune Pharmacol       Date:  2010-05-04       Impact factor: 4.147

4.  Prenatal opiate exposure attenuates LPS-induced fever in adult rats: role of interleukin-1beta.

Authors:  Kathryn L Hamilton; La 'Tonyia M Franklin; Sabita Roy; Lisa M Schrott
Journal:  Brain Res       Date:  2006-12-28       Impact factor: 3.252

5.  Interleukin-1 signaling in the basolateral amygdala is necessary for heroin-conditioned immunosuppression.

Authors:  Lee W Hutson; Christina L Lebonville; Meghan E Jones; Rita A Fuchs; Donald T Lysle
Journal:  Brain Behav Immun       Date:  2017-01-25       Impact factor: 7.217

Review 6.  Influence of opioids on immune function in patients with cancer pain: from bench to bedside.

Authors:  Jason W Boland; A Graham Pockley
Journal:  Br J Pharmacol       Date:  2017-07-23       Impact factor: 8.739

7.  Dual modulation of the T-cell receptor-activated signal transduction pathway by morphine in human T lymphocytes.

Authors:  Toshiyuki Mizota; Hiroshi Tsujikawa; Takehiro Shoda; Kazuhiko Fukuda
Journal:  J Anesth       Date:  2012-08-30       Impact factor: 2.078

8.  Evaluation of morphine effect on tumour angiogenesis in mouse breast tumour model, EATC.

Authors:  Funda Ustun; Gülay Durmus-Altun; Semsi Altaner; Nermin Tuncbilek; Cem Uzal; Sakir Berkarda
Journal:  Med Oncol       Date:  2010-06-22       Impact factor: 3.064

9.  Morphine-6beta-glucuronide modulates the expression of inducible nitric oxide synthase.

Authors:  D T Lysle; K A Carrigan
Journal:  Inflammation       Date:  2001-08       Impact factor: 4.092

10.  Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation.

Authors:  Timothy B Saurer; Stephanie G Ijames; Kelly A Carrigan; Donald T Lysle
Journal:  Brain Behav Immun       Date:  2007-08-03       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.